Cara Therapeutics reported $582.7M in Market Capitalization this January of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Acadia Pharmaceuticals ACAD:US $ 2.67B 1.24B
Acelrx Pharmaceuticals ACRX:US $ 0.12B 0.04B
Aerie Pharmaceuticals AERI:US $ 0.54B 0.21B
Antares Pharma ATRS:US $ 0.62B 0.12B
Arena Pharmaceuticals ARNA:US $ 3.64B 0.53B
Biodelivery Sciences International BDSI:US $ 0.36B 0B
Cara Therapeutics CARA:US $ 0.77B 0.06B
Chugai Pharma 4519:JP 6889.17B 502.04B
Depomed DEPO:US $ 0.04B 0.03B
Endo International Ordinary Shares ENDP:US 0.76B 0.34B
Halozyme Therapeutics HALO:US $ 5.79B 0.68B
Horizon Pharma HZNP:US 24.74B 3.7B
Johnson & Johnson JNJ:US $ 425.15B 8.68B
Neurocrine Biosciences NBIX:US $ 9.08B 0.12B
Pacira Pharmaceuticals PCRX:US $ 2.49B 0.18B
Pain Therapeutics PTIE:US $ 2.48B 0.93B
Pfizer PFE:US $ 241.14B 21.94B
Redhill Biopharma RDHL:US 0.21B 0.11B
Revance Therapeutics RVNC:US $ 2B 0.13B
Supernus Pharmaceuticals SUPN:US $ 1.42B 0.22B
Teva Pharmaceutical Industries TEVA:US 10.85B 0.13B
Vanda Pharmaceuticals VNDA:US $ 0.95B 0.24B